Opinion | Arkansas Gets Medicaid Back to Normal

[ad_1] The Covid-19 public-health emergency expanded the rolls, reducing resources for low-income and disabled people. [ad_2] Source link

Weight-Loss Drugmakers Lobby for Medicare Coverage

[ad_1] Adding Ozempic and Mounjaro to federal plans, whose prescription benefit excludes weight drugs, could stoke sales. [ad_2] Source link

Medicare Cracks Down on Deceptive Advertising, Service Denials by Privately-Run Plans

[ad_1] Health Rule comes after criticism that Medicare Advantage plans were running misleading ads [ad_2] Source link

Medicaid Eligibility Changes Set to Hit Hospitals, Insurers, States

[ad_1] Politics Health Policy Millions could lose coverage as their eligibility is reviewed, with financial effects rippling through the healthcare industry [ad_2] Source link

Social Security Reserves Projected to Run Out Earlier Than Expected

[ad_1] An economic slowdown, persistent inflation and weaker productivity growth will drain Social Security’s reserves one year earlier than previously estimated, the government said. [ad_2] Source link

Biden’s Budget Shows the Rising Cost of Leaving Medicare and Social Security Untouched

[ad_1] President Biden’s proposed budget assumes no cuts in benefits for the oldest Americans—and as a result their costs would continue to escalate. [ad_2] Source link

Biden’s Plan to Avert Medicare Funding Crisis Includes Tax Hikes on High Earners

[ad_1] Politics President to propose raising Medicare tax rates on people earning more than $400,000 a year [ad_2] Source link

CVS Makes $10 Billion Bet on Seniors

[ad_1] Despite government actions that have crimped profitability, CVS sees opportunity in expanding its Medicare Advantage business. [ad_2] Source link

The Government Thinks It Is Overpaying for Medicare, Spelling Trouble for Insurers

[ad_1] Markets Heard on the Street Health insurers had a stellar 2022, but this year looks more challenging [ad_2] Source link

New Alzheimer’s Drug Leqembi Will Be Out of Reach for Most Patients

[ad_1] Health Medicare won’t pay for medicine under rule issued to restrict use of earlier drug whose approval generated controversy [ad_2] Source link